VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 180 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 3.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $335,266 | -2.9% | 50,875 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $345,441 | -8.1% | 50,875 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $375,966 | -28.4% | 50,875 | -4.2% | 0.00% | -25.0% |
| Q3 2022 | $525,000 | -57.0% | 53,110 | -50.8% | 0.00% | -42.9% |
| Q1 2022 | $1,221,000 | -27.9% | 107,985 | 0.0% | 0.01% | -30.0% |
| Q4 2021 | $1,694,000 | -8.5% | 107,985 | 0.0% | 0.01% | -37.5% |
| Q3 2021 | $1,851,000 | -20.3% | 107,985 | 0.0% | 0.02% | -15.8% |
| Q2 2021 | $2,323,000 | +43.2% | 107,985 | 0.0% | 0.02% | +35.7% |
| Q1 2021 | $1,622,000 | +101.5% | 107,985 | +76.2% | 0.01% | +100.0% |
| Q4 2020 | $805,000 | +160.5% | 61,300 | +91.6% | 0.01% | +133.3% |
| Q3 2020 | $309,000 | -53.3% | 32,000 | -20.6% | 0.00% | -50.0% |
| Q4 2019 | $661,000 | -29.8% | 40,300 | -43.2% | 0.01% | -33.3% |
| Q3 2019 | $942,000 | – | 70,900 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Signpost Capital Advisors, LP | 1,688,952 | $27,327,000 | 10.37% |
| Palo Alto Investors LP | 3,240,424 | $52,430,000 | 3.90% |
| Parametrica Management Ltd | 12,509 | $202,000 | 1.53% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,740,400 | $28,160,000 | 1.08% |
| PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC | 557,100 | $9,014,000 | 1.07% |
| Westend Capital Management, LLC | 64,086 | $841,000 | 1.00% |
| WALL STREET ASSOCIATES | 702,700 | $11,370,000 | 0.98% |
| Baker Brothers Advisors | 4,372,153 | $70,741,000 | 0.87% |
| Iguana Healthcare Management, LLC | 100,000 | $1,618,000 | 0.76% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,085,301 | $17,560,000 | 0.71% |